Xencor
XNCR
#4335
Rank
โ‚ฌ2.32 B
Marketcap
30,95ย โ‚ฌ
Share price
-1.10%
Change (1 day)
126.51%
Change (1 year)

EPS for Xencor (XNCR)

EPS in 2026 (TTM): -1,35ย โ‚ฌ

According to Xencor's latest financial reports the company's current EPS (TTM) is -1,43ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,13ย โ‚ฌ an increase over its 2024 EPS that were of -3,30ย โ‚ฌ.

EPS history for Xencor from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,35ย โ‚ฌ19.54%
2025-1,13ย โ‚ฌ-65.84%
2024-3,30ย โ‚ฌ72.86%
2023-1,91ย โ‚ฌ128.26%
2022-0,84ย โ‚ฌ-164.79%
20211,29ย โ‚ฌ-217.36%
2020-1,10ย โ‚ฌ-346.94%
20190,45ย โ‚ฌ-136.57%
2018-1,22ย โ‚ฌ24.07%
2017-0,98ย โ‚ฌ-283.05%
20160,54ย โ‚ฌ-225.53%
2015-0,43ย โ‚ฌ-10.12%
2014-0,48ย โ‚ฌ-109.91%
20134,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,08ย โ‚ฌ-525.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
5,33ย โ‚ฌ-472.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,82ย โ‚ฌ-1,207.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,90ย โ‚ฌ-163.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,65ย โ‚ฌ 155.41%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
-0,52ย โ‚ฌ-63.69%๐Ÿ‡บ๐Ÿ‡ธ USA